<h4>Purpose</h4>The temozolomide (TMZ) resistance mechanisms in MGMT-promoter methylated <i>IDH</i> wildtype glioblastoma (GBM) tumors are poorly known. The gene discussed is MGMT; the disease is glioblastoma.